福安藥業(300194.SZ):收到企業境外投資證書及項目備案通知書
格隆匯12月24日丨福安藥業(300194.SZ)公佈,近日,子公司福安藥業集團寧波天衡製藥有限公司收到寧波市發展和改革委員會頒發的《項目備案通知書》(甬發改辦[2019]209號)、寧波市商務局頒發《企業境外投資證書》(境外投資證第N3302201900290號),現將相關信息公告如下:
《項目備案通知書》主要內容:
根據《企業境外投資管理辦法》(國家發展改革委令第11號),對福安藥業集團寧波天衡製藥有限公司通過子公司福安天衡(美國)有限公司(FuanTianheng(USA),LLC)收購福欣醫藥工業公司(Red Realty LLC)51%股權項目予以備案。本通知書有效期2年。
《企業境外投資證書》主要內容:
境外企業名稱:福欣醫藥工業公司;國家/地區:美國;設立方式:併購;投資主體:福安藥業集團寧波天衡製藥有限公司持股比例:51%,Shi Yuan Zhu持股比例:49%投資總額:中方52111.5萬元人民幣(摺合7350萬美元),外方49729.26萬元人民幣(摺合7014萬美元);經營範圍:藥品的生產及其附帶產品的回收;技術開發、服務;研究生產所需原材料的收購。核准或備案文號:甬境外投資[2019]N00287號;投資路徑公司名稱:福安天衡(美國)有限公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.